Pharmaron Beijing News

Kanglong Chemical: Oriental Securities Underwriting Sponsor Co., Ltd.'s sponsorship summary report on Kanglong Chemical (Beijing) Pharmaceutical Technology Co., Ltd.'s initial public offering of shares and listing on the GEM

Apr 4, 2023 15:40

Kanglong Chemical: 2021 Annual Equity Distribution Implementation Notice

Jun 7, 2022 18:44

Kanglong Chemical: Announcement on the progress of the acquisition of shares in overseas companies

Aug 30, 2021 00:00

Kanglong Chemical: Announcement on completing the issuance of $300 million zero-interest convertible bonds due in 2026 and zero-interest dollar settlement convertible bonds of RMB 1,916 million due in 2026

Jun 18, 2021 19:16

Kanglong Chemical: Announcement on the proposed issuance of $300 million zero-interest convertible bonds due in 2026 and $1,916 million dollar-settled zero-interest convertible bonds due in 2026

Jun 9, 2021 07:50

Kanglong Chemical: Announcement on Proposed Issuance of US Dollar Convertible Bonds and RMB Denominated US Dollar Settlement Convertible Bonds

Jun 8, 2021 16:22

Kanglong Chemical: Announcement on Acquisition of Shares in Overseas Companies

Mar 1, 2021 07:41

Kanglong Chemical: Announcement on Acquisition of Shares in Overseas Companies

Nov 9, 2020 07:41

Announcement on the temporary suspension of “N Kanglong” intraday trading

Jan 28, 2019 09:43

Announcement on the listing and trading of Kanglong Chemical (Beijing) New Pharmaceutical Technology Co., Ltd. shares on the GEM

Jan 24, 2019 17:24

Kanglong Chemical: China Securities Regulatory Commission's Approval to Approve the Company's Initial Public Offering of Shares

Jan 7, 2019 00:00